|
市場調査レポート
商品コード
1540804
骨密度計市場レポート:デバイスタイプ、技術、用途、エンドユーザー、地域別 2024-2032Bone Densitometer Market Report by Device Type, Technology (Dual-Energy X-Ray Absorptiometry, Single X-Ray Absorptiometry, Radiographic Absorptiometry, Quantitative Computed Tomography, and Others), Application, End-User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
骨密度計市場レポート:デバイスタイプ、技術、用途、エンドユーザー、地域別 2024-2032 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
|
骨密度計市場の世界市場規模は2023年に3億760万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに4億5,710万米ドルに達し、2024年から2032年の間に4.4%の成長率(CAGR)を示すと予測しています。
DXA装置とも呼ばれる骨密度計は、最小線量の電離放射線を利用して骨量と骨セグメント内のカルシウムやその他のミネラルの量を測定する装置を指します。DXA装置には、中央装置と周辺装置の2種類があります。中央装置は、股関節と脊椎の骨密度を測定するために使用され、通常、頭上にアームがある平らで広いものです。一方、周辺装置は小型で、主に手首、かかと、指の骨密度を調べるのに使用されます。骨粗鬆症の診断には特別な準備が必要なく、他の検査に比べ比較的短時間で済むため、標準的な方法とされています。また、骨粗鬆症性骨折の発症リスクの評価にも用いられます。
骨密度計市場の主な推進力のひとつは、骨に関連した病気にかかりやすい老年人口の増加です。これは、脆弱性骨折の発生件数の増加とともに、市場の成長に大きく寄与しています。これとは別に、これらの機器は骨粗鬆症や骨減少症の診断に極めて重要であるため、いくつかの病院やヘルスケアクリニックで骨密度検査に広く利用されています。DXAスキャナーの進歩により、より迅速で正確な診断が可能になったこと、既存のヘルスケアインフラを改善するための投資が増加していることなど、その他の要因も市場の見通しをさらに明るいものにすると予想されます。
The global bone densitometer market size reached US$ 307.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 457.1 Million by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032.
A bone densitometer, also known as a DXA machine, refers to a device that utilizes a minimal dose of ionizing radiation to measure bone loss and the amount of calcium and other minerals in a bone segment. There are two types of DXA equipment, namely central and peripheral devices. The central devices are used to measure the bone density of the hip and spine, and are usually flat and broad, with an arm overhead. On the other hand, peripheral devices are smaller in size and are mainly used to check bone density in wrists, heels, or fingers. It is the standardized method of diagnosing osteoporosis, as it requires no special preparations and a relatively shorter duration than other procedures. It is also used for assessing an individual's risk for developing osteoporotic fractures.
One of the major drivers of the bone densitometer market is the rise in geriatric population who are highly susceptible to bone-related ailments. This, along with the growing incidents of fragility fracture, is significantly contributing to the market growth. Apart from this, these devices are crucial in diagnosing osteoporosis and osteopenia, owing to which they are widely utilized for bone density testing in several hospitals and healthcare clinics. Other factors, such as advancements in DXA scanners, which have enabled quicker and more accurate diagnosis, along with increasing investments to improve the existing healthcare infrastructure, are expected to further create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone densitometer market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type, technology, application and end-user.
Axial Bone Densitometers
Peripheral Bone Densitometers
Dual-Energy X-Ray Absorptiometry (DXA)
Single X-Ray Absorptiometry (SXA)
Radiographic Absorptiometry (RA)
Quantitative Computed Tomography (QCT)
Others
Osteoporosis and Osteopenia Diagnosis
Cystic Fibrosis Diagnosis
Body Composition Measurement
Rheumatoid Arthritis Diagnosis
Others
Hospitals & Specialty Clinics
Diagnostics and Imaging Centers
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being Ampall Co. Ltd., BeamMed Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, GE Healthcare, Hologic Inc., Medonica Co. Ltd., Scanflex Healthcare AB, Swissray Global Healthcare Holding Ltd., etc.